AlphaYouKJ
Insider selling
Khurram Jamil sold $262K of Galectin Therapeutics Inc (GALT) stock
Khurram Jamil, Chief Medical Officer of Galectin Therapeutics Inc (GALT), sold 52,037 shares of GALT stock worth $262K, per an SEC Form 4 filed Jun 30, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 26, 2026, 4 days before it was made public.
GALT has moved -20.6% since the trade date, from $4.99 to $3.96 (Sep 21, 2026 close).
- Traded
- Jun 26, 2026
- Disclosed
- Jun 30, 2026
- Filing delay
- 4 days
- Price since
- -20.6%
- Role
- Chief Medical Officer
- Source
- SEC Form 4
More GALT insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.